ANKMJ
Ankyra Medical Journal

Ankyra Medical Journal (AnkMJ), formerly known as the Journal of Translational and Practical Medicine, regularly publishes international quality issues in the field of Medicine in the light of current information.

eISSN: 3023-655X
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
A hemodialysis case with fungemia due to Candida parapsilosis after COVID-19 infection
Abstract
Bacterial and fungal infections may emerge with or following COVID-19 infection. Corticosteroids, antibiotics, and other therapies utilized in severe cases of COVID-19 pneumonia may pose a risk for fungal infections. In this paper, we present the case of a 59-year-old female patient with underlying chronic renal failure and diabetes who received long-term corticosteroid therapy for COVID-19 pneumonia and subsequently developed fungemia and catheter infection due to Candida parapsilosis. We removed her subclavian catheter and administered amphotericin -B therapy for 37 days. Overall, we recommend keeping in mind that opportunistic fungal infections may emerge in patients receiving long-term immunosuppressive drug therapy due to COVID-19 with risk factors such as hemodialysis, central venous catheter use, and broad-spectrum antibiotic use.

Keywords : COVID-19, candida parapsilosis, catheter infection, fungemia

Download Article


1. Calvo GS, Araújo GRS, Pastor EL, et al. Candida spp. co-infectionin COVID-19 patients with severe pneumonia: Prevalencestudy and associated risk factors. Respir Med. 2021;188:106619.doi:10.1016/j.rmed.2021.106619.
2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinicalcharacteristics of 99 cases of 2019 novel Coronavirus pneumoniain Wuhan, China:a descriptive study. Lancet. 2020;395:507-513.doi:10.1016/S0140-6736(20)30211-7.
3. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the“Cytokine Storm” in COVID-19. J Infect. 2020;80:607-613.doi:10.1016/j.jinf.2020.03.037.
4. Zuo XS Liu Y, Cai X, Zhan L, Hu K. Association of differentCandida species with catheter-related candidemia, andthe potential antifungal treatments against their adhesionproperties and biofilm-forming capabilities. J Clin Lab Anal.2021;35(4):e23738. doi:10.1002/jcla.23738
5. Yamin DH, Husin A, Harun A. Risk factors of Candidaparapsilosis catheter-related bloodstream infection. Front PublicHealth. 2021;9:631865. doi.org/10.3389/fpubh.2021.631865.
6. Kayaaslan B, Kalem AK, Asilturk D, et al. Incidence and riskfactors for COVID-19 associated candidemia (CAC) in ICUpatients. Mycoses. 2022;65(5):508-516.
7. Liu F, Zhong L, Zhou F, et al. Clinical features, strain distribution,antifungal resistance and prognosis of patients with non-albicanscandidemia: a retrospective observational study. Infect DrugResist. 2021;14:3233-3246.
8. Coşkun AS, Durmaz ŞÖ. Fungal infections in COVID-19intensive care patients. Pol J Microbiol. 2021;70(3):395-400.
9. Zhang J, Lan P, Yi J, et al. Secondary bloodstream infectionin critically ill patients with COVID-19. J Int Med Res. 2021;49(12):3000605211062783. doi:10.1177/03000605211062783.
10. Martínez AR, Pascual IP, Guinea J, et al. Impact of the COVID-19pandemic on the clinical profile of candidemia and the incidenceof fungemia due to fluconazole-resistant Candida parapsilosis. JFungi (Basel) 2022;8(5):451. doi:10.3390/jof8050451.
Article available in :
Volume 2, Issue 1, 2023
Page : 26-29
https://doi.org/10.51271/JTPM-0036
Article Information
Received : 13 Şub 2023
Accepted : 26 Mar 2023
Published : 30 Nis 2023
Corresponding Author :

Salih Cesur: Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, University of Health Sciences, Ankara, TURKEY

[email protected]
Citation : Altun MS, Urtimur U, Cesur S, Kaya Kılıç E, Kınıklı S. A hemodialysis case with fungemia due to Candida parapsilosis after COVID-19 infection. J Transl Pract Med. 2023;2(1):27-30.

Read: 338
Cited: 0
Download : 156
_Footer